Prelude Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-35,500
Closed -$1.46M 1707
2018
Q2
$1.46M Buy
35,500
+7,800
+28% +$355K 0.09% 233
2018
Q1
$1.6M Buy
27,700
+6,800
+33% +$398K 0.12% 168
2017
Q4
$1.14M Buy
+20,900
New +$1.07M 0.09% 229
2017
Q3
Sell
-13,300
Closed -$771K 1596
2017
Q2
$771K Buy
13,300
+800
+6% +$46.5K 0.07% 252
2017
Q1
$731K Buy
12,500
+1,900
+18% +$108K 0.07% 282
2016
Q4
$589K Buy
+10,600
New +$567K 0.07% 293

Other funds holding ALKS

Prelude Capital Management's ALKS Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Alkermes (ALKS) in Q1 2026: 16,928 shares worth $599K. The stake represents 0.05% of the portfolio and ranks #441 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in ALKS as recently as Q2 2021.

Prelude Capital Management first reported a position in ALKS in Q3 2013 and has held it in 12 quarters since. The position peaked at $652K in Q4 2015. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Prelude Capital Management held 16,928 shares of Alkermes worth $599K as of Q1 2026.
  • Alkermes was a new Prelude Capital Management position in Q1 2026.
  • Alkermes made up 0.05% of Prelude Capital Management's portfolio in Q1 2026, its #441 holding.
  • Prelude Capital Management first reported a position in Alkermes in Q3 2013 and has held it in 12 quarters since.
  • Prelude Capital Management's Alkermes position peaked at $652K in Q4 2015.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.